F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based
observation, medical record review, contingency medication box medication list review, staff interview, and
review of a facility policy, the facility failed to ensure newly admitted residents had medications pulled from
the contingency medication supply and administered the night of admission as ordered. This affected two
(#11 and #67) of three residents reviewed for medications. The facility census was 63.
Findings include:
1. Review of Resident #11's medical record revealed admission to the facility on [DATE] with medical
diagnoses including morbid obesity, kidney failure, anxiety, and congestive heart failure (CHF).
Review of Resident #11's hospital discharge medications list prior to admission included the muscle
relaxant cyclobenzaprine five (5) milligrams and the pain medication Neurontin 600 mg were ordered for
bedtime.
Review of Resident #11's progress notes revealed the resident arrived to the facility on [DATE] at 6:45 P.M.
Review of Resident #11's February 2024 medication administration record (MAR) revealed at bedtime on
02/02/24 the resident did not receive any of her ordered medications. Further review of the MAR identified
the medications were not available.
2. Review of Resident #67's medical record revealed admission to the facility on [DATE] with diagnoses
including respiratory failure, ventilator dependence, morbid obesity, and congestive heart failure (CHF).
Review of Resident #67's hospital medication discharge list prior to admission included the diuretic Lasix
40 mg due at bedtime. The hospital records identified the last dose of Lasix given to Resident #67 occurred
on 01/08/24 at 8:35 A.M.
Review of Resident #67's January 2024 MAR revealed on 01/08/24 the Lasix 40 mg was not given at 8:00
P.M. as order as it was identified as not available.
Observation of the facility's contingency medication box was completed on 02/27/24. The box was observed
with a listing of all medications that were available to staff. Review of the medication list of what was
available in the contingency medication box on 02/27/24 revealed the box contained cyclobenzaprine 5 mg,
Neurontin 600 mg, and Lasix 40 mg which were available and could have been
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365681
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365681
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Windsor Lane Healthcare Center
355 Windsor Lane
Gibsonburg, OH 43431
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
administered to Resident #11 and Resident #67 upon their admissions to the facility. Further review of the
contingency medication box revealed no indication cyclobenzaprine 5 mg and Neurontin 600 mg where
pulled for Resident #11 on 02/02/24 or Lasix 40 mg was pulled for Resident #67 on 01/08/24.
Interview with the Director of Nursing (DON) on 02/27/24 at 9:40 A.M. confirmed staff should pull any
medications not in the facility from the contingency medication box to administer to residents. The interview
confirmed medications were not pulled from the contingency medication box upon admission for Resident
#11 and Resident #67, and the DON confirmed Resident #11 and Resident #67 did not receive
medications as ordered at bedtime on the day of each resident's admission to the facility.
Review of the facility contingency cabinet medications policy, dated 01/17/24, revealed the purpose of the
box was listed to ensure supply of commonly used medication are maintained in the facility by the
pharmacy in order to initiate stat therapies until a regular supply of medication can be obtained. The box
may include any medications deemed necessary by the facility pharmaceutical committee.
This deficiency represents non-compliance investigated under Complaint Number OH00150756.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365681
If continuation sheet
Page 2 of 2